Alzamend Neuro (ALZN) Other financing activities (2021)

Alzamend Neuro has disclosed Other financing activities across 1 years of filings, most recently posting $12.9 million for Q3 2021.

• In Q3 2021, Other financing activities changed N/A year-over-year to $12.9 million; the TTM figure through Apr 2022 stood at $12.9 million (changed N/A YoY), while the FY2025 annual figure was $600.0, changed N/A from the prior year.
• Other financing activities came in at $12.9 million for Q3 2021 at Alzamend Neuro.
• In the past five years, Other financing activities ranged from a high of $12.9 million in Q3 2021 to a low of $12.9 million in Q3 2021.